Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D H Nieman

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Psychological Medicine|July 5, 2014
Adapted cognitive-behavioural therapy required for targeting negative symptoms in schizophrenia: meta-analysis and meta-regressionE Velthorst, M Koeter, M van der Gaag, et al.
Acta Psychiatrica Scandinavica|April 28, 2009
Early intervention in patients at ultra high risk of psychosis: benefits and risksM B de Koning, O J N Bloemen, T A M J van Amelsvoort, et al.
Psychological Medicine|February 6, 2010
Neurocognitive functioning before and after the first psychotic episode: does psychosis result in cognitive deterioration?H E Becker, D H Nieman, S Wiltink, et al.
Psychological Medicine|August 13, 2011
Ethnicity and baseline symptomatology in patients with an At Risk Mental State for psychosisE Velthorst, D H Nieman, W Veling, et al.
Psychological Medicine|November 10, 2009
White-matter markers for psychosis in a prospective ultra-high-risk cohortO J N Bloemen, M B de Koning, N Schmitz, et al.
Psychological Medicine|October 22, 2014
Cost-effectiveness of preventing first-episode psychosis in ultra-high-risk subjects: multi-centre randomized controlled trialH K Ising, F Smit, W Veling, et al.
Psychological Medicine|May 20, 2016
Distinct white-matter aberrations in 22q11.2 deletion syndrome and patients at ultra-high risk for psychosisG Bakker, M W A Caan, R S Schluter, et al.
Psychological Medicine|March 17, 2016
Development of a stage-dependent prognostic model to predict psychosis in ultra-high-risk patients seeking treatment for co-morbid psychiatric disordersH K Ising, S Ruhrmann, N A F M Burger, et al.
Acta Psychiatrica Scandinavica|July 11, 2012
The Strauss and Carpenter Prognostic Scale in subjects clinically at high risk of psychosisD H Nieman, E Velthorst, H E Becker, et al.
Acta Psychiatrica Scandinavica|September 3, 2011
Cannabis use and age at onset of symptoms in subjects at clinical high risk for psychosisS Dragt, D H Nieman, F Schultze-Lutter, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Psychological Medicine|July 5, 2014
Adapted cognitive-behavioural therapy required for targeting negative symptoms in schizophrenia: meta-analysis and meta-regressionE Velthorst, M Koeter, M van der Gaag, et al.
Acta Psychiatrica Scandinavica|April 28, 2009
Early intervention in patients at ultra high risk of psychosis: benefits and risksM B de Koning, O J N Bloemen, T A M J van Amelsvoort, et al.
Psychological Medicine|February 6, 2010
Neurocognitive functioning before and after the first psychotic episode: does psychosis result in cognitive deterioration?H E Becker, D H Nieman, S Wiltink, et al.
Psychological Medicine|August 13, 2011
Ethnicity and baseline symptomatology in patients with an At Risk Mental State for psychosisE Velthorst, D H Nieman, W Veling, et al.
Psychological Medicine|November 10, 2009
White-matter markers for psychosis in a prospective ultra-high-risk cohortO J N Bloemen, M B de Koning, N Schmitz, et al.
Psychological Medicine|October 22, 2014
Cost-effectiveness of preventing first-episode psychosis in ultra-high-risk subjects: multi-centre randomized controlled trialH K Ising, F Smit, W Veling, et al.
Psychological Medicine|May 20, 2016
Distinct white-matter aberrations in 22q11.2 deletion syndrome and patients at ultra-high risk for psychosisG Bakker, M W A Caan, R S Schluter, et al.
Psychological Medicine|March 17, 2016
Development of a stage-dependent prognostic model to predict psychosis in ultra-high-risk patients seeking treatment for co-morbid psychiatric disordersH K Ising, S Ruhrmann, N A F M Burger, et al.
Acta Psychiatrica Scandinavica|July 11, 2012
The Strauss and Carpenter Prognostic Scale in subjects clinically at high risk of psychosisD H Nieman, E Velthorst, H E Becker, et al.
Acta Psychiatrica Scandinavica|September 3, 2011
Cannabis use and age at onset of symptoms in subjects at clinical high risk for psychosisS Dragt, D H Nieman, F Schultze-Lutter, et al.
Pageof 3